Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Post-Marketing, Sentinel-based Active Surveillance Study to Evaluate the Safety of Ampholipad Using Real-World Data in Taiwan

NCT03641131 is registered in ClinicalTrials.gov with Taiwan Liposome Company as lead sponsor.

NCT NCT03641131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03641131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Post-Marketing, Sentinel-based Active Surveillance Study to Evaluate the Safety of Ampholipad Using Real-World Data in Taiwan
Lead sponsor
Taiwan Liposome Company
Phase
Observational
Overall status
Completed
Start date
September 9, 2018
Completion date
January 8, 2019
Enrollment
102 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aspergillus infection, candida infection, cryptococcal infections, febrile neutropenia, fungal infection